Clinical Trials Browser

Interventional × Uveal Melanoma × peginterferon alfa-2b × Clear all

NCT00238329 2013-04-08

PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma

Phase 2 Completed

Uveal Melanoma, Melanoma